Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
Haemophilus paraphrophilus
Perilipin-4
RNA, Ribosomal, 16S
Relapse risk after discontinuation of risperidone in Alzheimer's disease.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Relapse risk after discontinuation of risperidone in Alzheimer's disease.
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Aggression
Alzheimer Disease
Antipsychotic Agents
Double-Blind Method
Female
Humans
Male
Psychomotor Agitation
Psychotic Disorders
Recurrence
Risk
Risperidone
Substance Withdrawal Syndrome
authors with profiles
Jacobo E Mintzer